Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep371 | Cardiovascular Endocrinology and Lipid Metabolism | ECE2017

Metformin and changes in serum lipid profile in lean patients with polycystic ovary syndrome (PCOS)

Kialka Marta , Milewicz Tomasz , Wajda Anna , Czekanska Patrycja , Zdzierak Barbara , Mrozinska Sandra

Introduction: The aim of our study was to assess the values of total cholesterol, HDL-C, LDL-C and triglycerides before and after treatment with metformin in patients with polycystic ovary syndrome (PCOS) and normal lean.Material and methods: 32 patients received metformin 1500 mg/day in three divided doses. Lipids measurements were performed to each patient with PCOS twice: before and after 6 months of treatment with metformin.Res...

ea0049ep1148 | Female Reproduction | ECE2017

Metformin treatment decreased free androgen index among PCOS women

Mrozinska Sandra , Wajda Anna , Czekanska Patrycja , Zdzierak Barbara , Kialka Marta , Milewicz Tomasz

: Hyperinsulinemia is one of biochemical features of polycystic ovary syndrome (PCOS). Metformin is a common drug used in PCOS. Recent studies have shown that metformin has impact on clinical and biochemical parameters in PCOS patients. The aim of our study was to assess retrospectively the influence of metformin on total testosterone, sex hormone binding globulin (SHBG) and free androgen index (FAI) in women with PCOS in polish cohort. A total of 54 patients with PCOS and irr...